OpenAlex
PricingAboutJobs
Log inGet started
Work

Abstract 1306: Radionuclide-specific effects of 90Y-, 177Lu-, or 225Ac-NM600 targeted radionuclide therapy on tumor immunomodulation and enhancing immunotherapy response in murine tumor models

HTML

Year: 2022
Type: conference-abstract
Source: Cancer Research
DOI: 10.1158/1538-7445.am2022-1306
Authors: Caroline P. Kerr, Amber M. Bates, Joseph J. Grudzinski, Carolina A. Ferreira, Julia Sheehan-Klenk, David Adam, Maria Powers, Wonjong Jin, Justin C. Jagodinsky, Raghava N. Sriramaneni, Paul A. Clark, Luke Zangl, Anatoly N. Pinchuk, Alejandro J. Onate, Ria Kumari, Cynthia Choi, Christopher F. Massey, Bryan Bednarz, Reinier Hernandez, Jamey P. Weichert, Zachary S. Morris
Institution: University of Wisconsin–Madison
Language: English

Topic: Radiopharmaceutical Chemistry and Applications
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Keywords: targeted radionuclide therapy, tumor immunomodulation, immune checkpoint inhibitors, anti-CTLA-4, PD-L1 inhibitors, low-dose radiation, STING, head and neck squamous cell carcinoma, melanoma, tumor-infiltrating immune cells, dosimetry
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4282979331
Cites:
Cited by: 1
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security